Odsorption dry cholera diagnostic serums Ogawa and Inaba for agglutination reaction (RA) as per TU 8938-010-01898109-2007
- Device Name (English)
- Odsorption dry cholera diagnostic serums Ogawa and Inaba for agglutination reaction (RA) as per TU 8938-010-01898109-2007
- Device Name (Russian)
- Сыворотки диагностические холерные Огава и Инаба адсорбированные сухие для реакции агглютинации (РА) по ТУ 8938-010-01898109-2007
- Device Type (English)
- N/A
- Device Type (Russian)
- 190150
- Risk Class
- Class 2b
- OKPD Code
- 21.20.23.110
- Registry Key
- 65912.0
- Registration Number
- ФСР 2007/00467
- Registration Date
- September 28, 2022
- Manufacturer Name (English)
- Russian Anti-Plague Institute "Microbe" of Rospotrebnadzor
- Manufacturer Name (Russian)
- ФКУН Российский противочумный институт "Микроб" Роспотребнадзора
- Country (English)
- Russia
- Country (Russian)
- Россия
- Legal Address (English)
- Russian Anti-Plague Institute "Microbe" of Rospotrebnadzor, Russia, 410005, Saratov, Universitetskaya str., 46
- Legal Address (Russian)
- ФКУН Российский противочумный институт "Микроб" Роспотребнадзора, Россия, 410005, г. Саратов, ул. Университетская, д. 46
- Manufacturing Address
- 410005, Россия, Саратовская область, г. Саратов, ул. Университетская, д. 46
Access comprehensive regulatory information for Odsorption dry cholera diagnostic serums Ogawa and Inaba for agglutination reaction (RA) as per TU 8938-010-01898109-2007 in the Russia medical device market through Pure Global AI's free database. This Class 2b medical device is registered under Roszdravnadzor registration number ФСР 2007/00467 and manufactured by Russian Anti-Plague Institute "Microbe" of Rospotrebnadzor. The device was registered on September 28, 2022.
This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.